Richard I Steinhart - Net Worth and Insider Trading
Richard I Steinhart Net Worth
The estimated net worth of Richard I Steinhart is at least $11,147 dollars as of 2024-05-14. Richard I Steinhart is the CFO of BioXcel Therapeutics Inc and owns about 4,765 shares of BioXcel Therapeutics Inc (BTAI) stock worth over $10,316. Richard I Steinhart is also the Director of Actinium Pharmaceuticals Inc and owns about 83 shares of Actinium Pharmaceuticals Inc (ATNM) stock worth over $830. Details can be seen in Richard I Steinhart's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard I Steinhart has not made any transactions after 2024-04-04 and currently still holds the listed stock(s).
Transaction Summary of Richard I Steinhart
Richard I Steinhart Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard I Steinhart owns 5 companies in total, including Actinium Pharmaceuticals Inc (ATNM) , BioXcel Therapeutics Inc (BTAI) , and Atossa Therapeutics Inc (ATOS) among others .
Click here to see the complete history of Richard I Steinhart’s form 4 insider trades.
Insider Ownership Summary of Richard I Steinhart
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATNM | Actinium Pharmaceuticals Inc | 2016-04-14 | director |
| BTAI | BioXcel Therapeutics Inc | 2024-04-04 | Chief Financial Officer |
| ATOS | Atossa Therapeutics Inc | 2014-03-01 | director |
 | | 2006-04-24 | Chief Financial Officer |
| | 2010-03-03 | director |
Richard I Steinhart Latest Holdings Summary
Richard I Steinhart currently owns a total of 2 stocks. Among these stocks, Richard I Steinhart owns 4,765 shares of BioXcel Therapeutics Inc (BTAI) as of April 4, 2024, with a value of $10,316 and a weighting of 92.55%. Richard I Steinhart also owns 83 shares of Actinium Pharmaceuticals Inc (ATNM) as of April 14, 2016, with a value of $830 and a weighting of 7.45%.
Latest Holdings of Richard I Steinhart
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BTAI | BioXcel Therapeutics Inc | 2024-04-04 | 4,765 | 2.17 | 10,316 |
| ATNM | Actinium Pharmaceuticals Inc | 2016-04-14 | 83 | 10.00 | 830 |
Holding Weightings of Richard I Steinhart
Richard I Steinhart Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard I Steinhart has made a total of 4 transactions in BioXcel Therapeutics Inc (BTAI) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in BioXcel Therapeutics Inc is the sale of 1,069 shares on April 4, 2024, which brought Richard I Steinhart around $2,822.
According to the SEC Form 4 filings, Richard I Steinhart has made a total of 0 transactions in Actinium Pharmaceuticals Inc (ATNM) over the past 5 years. The most-recent trade in Actinium Pharmaceuticals Inc is the acquisition of 83 shares on April 14, 2016, which cost Richard I Steinhart around $5,025.
Insider Trading History of Richard I Steinhart
- 1
Richard I Steinhart Trading Performance
GuruFocus tracks the stock performance after each of Richard I Steinhart's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard I Steinhart is 56.28%. GuruFocus also compares Richard I Steinhart's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard I Steinhart within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard I Steinhart's insider trading performs compared to the benchmark.
Performance of Richard I Steinhart
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.87 | | | | | |
| Relative Return to S&P 500(%) | -3.58 | | | | | |
Richard I Steinhart Ownership Network
Richard I Steinhart Owned Company Details
What does Actinium Pharmaceuticals Inc do?
Who are the key executives at Actinium Pharmaceuticals Inc?
Richard I Steinhart is the director of Actinium Pharmaceuticals Inc. Other key executives at Actinium Pharmaceuticals Inc include VP & Finance and Corporate Dev. Steve O'loughlin , Chief Scientific Officer Dale L. Ludwig , and Chief Commercial Officer Anil Kapur .
Actinium Pharmaceuticals Inc (ATNM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Actinium Pharmaceuticals Inc (ATNM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Actinium Pharmaceuticals Inc (ATNM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Actinium Pharmaceuticals Inc (ATNM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Actinium Pharmaceuticals Inc Insider Transactions
Richard I Steinhart Mailing Address
Above is the net worth, insider trading, and ownership report for Richard I Steinhart. You might contact Richard I Steinhart via mailing address: 125 Elm Street, New Canaan Ct 06840.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
